<VariationArchive VariationID="2883386" VariationName="NM_173551.5(ANKS6):c.1683_1698dup (p.Phe567fs)" VariationType="Duplication" Accession="VCV002883386" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-29" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3050026" VariationID="2883386">
      <GeneList>
        <Gene Symbol="ANKS6" FullName="ankyrin repeat and sterile alpha motif domain containing 6" GeneID="203286" HGNC_ID="HGNC:26724" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="98732009" stop="98796555" display_start="98732009" display_stop="98796555" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="101494290" stop="101558793" display_start="101494290" display_stop="101558793" Strand="-" />
          </Location>
          <OMIM>615370</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_173551.5(ANKS6):c.1683_1698dup (p.Phe567fs)</Name>
      <CanonicalSPDI>NC_000009.12:98773999:ACTGGAAGGGGGTAGGA:ACTGGAAGGGGGTAGGACTGGAAGGGGGTAGGA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9q22.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="98773999" stop="98774000" display_start="98773999" display_stop="98774000" variantLength="16" positionVCF="98773999" referenceAlleleVCF="A" alternateAlleleVCF="AACTGGAAGGGGGTAGG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="101536281" stop="101536282" display_start="101536281" display_stop="101536282" variantLength="16" positionVCF="101536281" referenceAlleleVCF="A" alternateAlleleVCF="AACTGGAAGGGGGTAGG" />
      </Location>
      <ProteinChange>F567fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.101536283_101536298dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.101536283_101536298dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.98774001_98774016dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.98774001_98774016dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_042237.1" sequenceAccession="NG_042237" sequenceVersion="1" change="g.27528_27543dup">
            <Expression>NG_042237.1:g.27528_27543dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_173551.5" sequenceAccession="NM_173551" sequenceVersion="5" change="c.1683_1698dup" MANESelect="true">
            <Expression>NM_173551.5:c.1683_1698dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_775822.3" sequenceAccession="NP_775822" sequenceVersion="3" change="p.Phe567fs">
            <Expression>NP_775822.3:p.Phe567fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_173551.5(ANKS6):c.1683_1698dup (p.Phe567fs) AND Nephronophthisis 16" Accession="RCV003742517" Version="1">
        <ClassifiedConditionList TraitSetID="11734">
          <ClassifiedCondition DB="MedGen" ID="C3809320">Nephronophthisis 16</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-08" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23793029</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25599650</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="11734" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18247" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis 16</ElementValue>
                <XRef ID="MONDO:0014158" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NPHP16</ElementValue>
                <XRef Type="MIM" ID="615382" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18183" />
                <XRef ID="18183" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-LÃ¸ken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C3809320" DB="MedGen" />
              <XRef ID="MONDO:0014158" DB="MONDO" />
              <XRef Type="MIM" ID="615382" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8296208" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="5606428|MedGen:C3809320" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004507240" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23793029</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25599650</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant has not been reported in the literature in individuals affected with ANKS6-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Phe567Profs*7) in the ANKS6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ANKS6 are known to be pathogenic (PMID: 23793029, 25599650).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANKS6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.101536281_101536282insACTGGAAGGGGGTAGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3809320" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8296208" TraitType="Disease" MappingType="XRef" MappingValue="C3809320" MappingRef="MedGen">
        <MedGen CUI="C3809320" Name="Nephronophthisis 16" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

